The Ascend $791M Fund has closed above expectations, signaling fresh momentum in healthcare private equity as Ascend Capital Partners announced Wednesday it secured $791 million in capital commitments for its second fund.
Advised by Kirkland & Ellis LLP, the healthcare-focused investment firm surpassed its initial $700 million target, underscoring strong investor appetite for its strategy.
Fund II Outpaces Its Predecessor
The new vehicle, Ascend Capital Partners Fund II LP, not only beat its goal but also eclipsed the firm’s inaugural fund, which closed at its $570 million hard cap in December 2021 and has since been fully deployed across eight investments.
The second fund is aimed squarely at physician and provider services, value-based care enablement platforms and healthcare information technology companies. Ascend said it will continue working alongside physicians, clinical leaders and management teams to build scalable healthcare platforms designed to enhance clinical quality and foster sustainable growth.
